Main menu

NCM 2022: Identification of Leishmania infantum epidemiological, drug resistance and pathogenicity biomarkers


  • Leishmania infantum is a protist parasite and causative agent of leishmaniasis, endemic to many countries world-wide, per example the Mediterranean basin.
  • Emerging drug-resistant L. infantum is one of the most relevant neglected tropical disease, as it is responsible for 12M infections w/w and more than 25,000 deaths.
  • It possesses a genome of 32 Mb distributed in 36 chromosomes and a complex network of maxi- and minicircle kinetoplasts (functionally similar to mitochondria).
  • Its genome is structurally complex, with frequent rearrangements and aneuploidies. Such changes in copy number variation (CNV) occur as a result of environment adaptation and can be potentially used as genetic biomarkers to create a genetic resistance profile.

Download the PDF

入門

MinION Starter Packを購入 ナノポア製品の販売 シークエンスサービスプロバイダー グローバルディストリビューター

ナノポア技術

ナノポアの最新ニュースを購読 リソースと発表文献 Nanopore Communityとは

Oxford Nanoporeについて

ニュース 会社沿革 持続可能性 経営陣 メディアリソース & お問い合わせ先 投資家向け パートナー向け Oxford Nanopore社で働く 現在の募集状況 営業上の情報 BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust
Japanese flag